Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gilead Sciences
(NQ:
GILD
)
65.61
+0.41 (+0.62%)
Streaming Delayed Price
Updated: 11:42 AM EDT, May 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Gilead Sciences
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
Large Cap Biopharmaceuticals Performance 2023 YTD: Mixed Results But Lilly Is A Big Winner
August 21, 2023
Biotech stocks are in a bear market since the IBB hit $177.37 in 2021 and is down 7.84% over five years.
Via
Talk Markets
FDA Pauses Gilead's Investigational Magrolimab Study In Blood Cancer Patients
August 21, 2023
FDA has placed a partial clinical hold on Gilead Sciences Inc (NASDAQ: GILD) initiation of new patients in U.S.
Via
Benzinga
Exposures
Product Safety
5 Safe Stocks Under $40 to Buy Immediately
August 21, 2023
Investors are turning away from risky bets and putting their money in safe stocks this week. Here are four names under $40 to buy now.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
August 17, 2023
Via
Benzinga
$1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth This Much Today
August 11, 2023
Via
Benzinga
How Is The Market Feeling About Gilead Sciences?
August 10, 2023
Via
Benzinga
2 High-Yield Dividend Stocks to Buy on the Dip
August 08, 2023
The market may have been a bit too harsh on these stocks.
Via
The Motley Fool
Autolus Therapeutics' Obe-Cel's Shows Compelling Safety Over Gilead's Drug For Acute Lymphoblastic Leukemia
August 17, 2023
Truist has raised the price target for Autolus Therapeutics PLC (NASDAQ: AUTL) from $6 to $9
Via
Benzinga
The 3 Best Biotech Stocks to Buy in August
August 09, 2023
Even as healthcare stocks suffer from post-pandemic fatigue, these three of the best biotech stocks to buy and ride the wave of good news.
Via
InvestorPlace
Gilead Stock Jumps On Strong Q2 Performance Despite Lower Profit Outlook Amid Litigation
August 04, 2023
Gilead Sciences Inc's (NASDAQ: GILD) Q2 FY23 sales increased 6% Y/Y to $6.60 billion, above the consensus of $6.43 billion, primarily driven by increased sales in HIV and Oncology, partially offset by...
Via
Benzinga
Gilead Sciences (GILD) Q2 2023 Earnings Call Transcript
August 04, 2023
GILD earnings call for the period ending June 30, 2023.
Via
The Motley Fool
Will An Earnings Miss Cloud Gilead's Massive Cancer Treatment Growth?
August 03, 2023
Gilead missed earnings expectations Thursday, though reported strong sales growth for cancer drugs.
Via
Investor's Business Daily
US Stock Futures Dip As Apple, Amazon Earnings Loom: Analyst Warns Of 'Perfectly Normal' 5% Pullback This Month
August 03, 2023
Stocks appear to be entrenched in an August swoon and it remains to be seen if big tech earnings provide a boost.
Via
Benzinga
$1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth This Much Today
July 31, 2023
Via
Benzinga
Market Rally Under Pressure As Yields Soar; Amazon, ELF, Caterpillar Are Earnings Winners: Weekly Review
August 04, 2023
Amazon, ELF and CAT were earnings winners, but there were big losers too.
Via
Investor's Business Daily
Buy Alert: 3 Biotech Stocks Nearing Super Attractive Entry Points
August 01, 2023
Investors looking to give their portfolio a boost should consider one of these leading biotech names, which are undervalued right now.
Via
InvestorPlace
3 Stocks Retirees Should Absolutely Love
July 29, 2023
These stocks offer solid income plus more.
Via
The Motley Fool
Expert Ratings for Gilead Sciences
July 24, 2023
Via
Benzinga
Peering Into Gilead Sciences's Recent Short Interest
July 19, 2023
Via
Benzinga
Here's How Much $1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth Today
July 18, 2023
Via
Benzinga
Trial Setback For Gilead Sciences: Shuts Late-Stage Magrolimab/Azacitidine Combo Study In Type Of Blood Cancer
July 24, 2023
Gilead Sciences Inc (NASDAQ: GILD) decided to discontinue the Phase 3 ENHANCE study in higher-risk myelodysplastic syndromes (MDS) due to futility
Via
Benzinga
Bank of America, Bank of New York Mellon And 2 Other Stocks Insiders Are Selling
July 24, 2023
The Nasdaq 100 closed slightly higher on Friday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Governor DeSantis Says He Would Sue the Drug Company Gilead for Trying to Save Lives
July 23, 2023
DeSantis made it clear that he thinks companies should only maximize profit and be subject to shareholder lawsuits if they do anything other than maximizing profits. So how does this get us to suing...
Via
Talk Markets
2 Growth Stocks That Could Rocket 81% to 233% Higher, According to Wall Street
July 20, 2023
The investment bank analysts who follow these stocks think they could deliver enormous gains in the not-so-distant future.
Via
The Motley Fool
The 7 Most Undervalued Nasdaq Stocks to Buy Now: July 2023
July 19, 2023
The market is soaring, but there is still time to buy these seven undervalued Nasdaq stocks before they head higher.
Via
InvestorPlace
Price Over Earnings Overview: Gilead Sciences
July 17, 2023
Via
Benzinga
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
July 19, 2023
It helps to offer products everyone needs.
Via
The Motley Fool
SARS-CoV-2 Is Not Done Yet — Could This New Drug In Clinical Trials Be The Safest Option For Treating COVID-19?
July 18, 2023
Read the latest report on NanoViricides here.
Via
Benzinga
Buying These 2 Stocks Is a Good Way to Hedge Against a Market Crash
July 17, 2023
These stocks are built to withstand a bear market.
Via
The Motley Fool
FDA Approves Gilead's Remdesivir For COVID-19 Treatment Patients With Severe Renal Impairment
July 14, 2023
The FDA approved Gilead Sciences Inc's (NASDAQ: GILD) supplemental new drug application for using Veklury (remdesivir) in COVID-19 patients with severe renal impairment,
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.